REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 152 filers reported holding REVANCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,119,082 | -54.1% | 184,750 | +1.2% | 0.00% | -33.3% |
| Q2 2023 | $4,620,341 | -19.2% | 182,550 | +2.8% | 0.00% | -25.0% |
| Q1 2023 | $5,718,886 | +58.2% | 177,550 | -9.3% | 0.00% | +33.3% |
| Q4 2022 | $3,615,391 | -30.1% | 195,850 | +2.2% | 0.00% | -25.0% |
| Q3 2022 | $5,172,000 | +132.1% | 191,550 | +18.8% | 0.00% | +100.0% |
| Q2 2022 | $2,228,000 | -29.1% | 161,250 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $3,144,000 | +28.9% | 161,250 | +7.9% | 0.00% | +100.0% |
| Q4 2021 | $2,439,000 | -41.4% | 149,450 | 0.0% | 0.00% | -66.7% |
| Q3 2021 | $4,164,000 | -6.0% | 149,450 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $4,430,000 | +15.9% | 149,450 | +9.3% | 0.00% | 0.0% |
| Q1 2021 | $3,822,000 | +0.5% | 136,750 | +1.9% | 0.00% | 0.0% |
| Q4 2020 | $3,802,000 | +30.0% | 134,150 | +15.3% | 0.00% | +50.0% |
| Q3 2020 | $2,925,000 | +4.7% | 116,350 | +1.7% | 0.00% | 0.0% |
| Q2 2020 | $2,795,000 | +109.7% | 114,450 | +27.1% | 0.00% | +100.0% |
| Q1 2020 | $1,333,000 | -7.7% | 90,050 | +1.2% | 0.00% | 0.0% |
| Q4 2019 | $1,444,000 | +51.4% | 88,950 | +21.3% | 0.00% | 0.0% |
| Q3 2019 | $954,000 | +0.3% | 73,350 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $951,000 | -13.2% | 73,350 | +5.6% | 0.00% | 0.0% |
| Q1 2019 | $1,095,000 | +4.1% | 69,450 | +32.9% | 0.00% | 0.0% |
| Q4 2018 | $1,052,000 | -17.1% | 52,250 | +2.4% | 0.00% | 0.0% |
| Q3 2018 | $1,269,000 | -9.4% | 51,050 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $1,401,000 | -10.9% | 51,050 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $1,572,000 | -14.8% | 51,050 | -1.2% | 0.00% | 0.0% |
| Q4 2017 | $1,846,000 | +88.9% | 51,650 | +45.7% | 0.00% | +100.0% |
| Q3 2017 | $977,000 | +12.7% | 35,450 | +7.9% | 0.00% | 0.0% |
| Q2 2017 | $867,000 | +26.9% | 32,850 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $683,000 | +7.2% | 32,850 | +6.8% | 0.00% | 0.0% |
| Q4 2016 | $637,000 | +27.9% | 30,750 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $498,000 | +19.1% | 30,750 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $418,000 | -19.3% | 30,750 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $518,000 | -38.7% | 30,750 | +24.2% | 0.00% | -50.0% |
| Q4 2015 | $845,000 | +36.3% | 24,750 | +18.7% | 0.00% | 0.0% |
| Q3 2015 | $620,000 | -0.3% | 20,850 | +7.2% | 0.00% | 0.0% |
| Q2 2015 | $622,000 | +132.1% | 19,450 | +50.2% | 0.00% | +100.0% |
| Q1 2015 | $268,000 | +22.4% | 12,950 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $219,000 | +7.4% | 12,950 | +22.7% | 0.00% | 0.0% |
| Q3 2014 | $204,000 | -43.2% | 10,550 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $359,000 | – | 10,550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
| Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
| Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
| ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
| Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
| Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |